Section: Module 2 : Overview of Buprenorphine | Buprenorphine Training: Treating Opioid Use Disorder

Section: Module 2 : Overview of Buprenorphine | Buprenorphine Training: Treating Opioid Use Disorder | NextGenU.org

Competency covered in this module:

Gain a comprehensive understanding of Buprenorphine, its mechanism of action, and its role in treating opioid overdoses.

Understand the pharmacokinetics and pharmacodynamics of Buprenorphine.

Learn about the potential side effects and contraindications of Buprenorphine.

Learn about both existing and emerging Buprenorphine formulations.

Approximate time required for the readings for this module (at 144 words/minute): 3 hours 9 minutes.
- Select activity Module Summary:Please review the learning resource...
  
  Module Summary:
  
  Please review the learning resource summarizing the key concepts and information for Module 2. This resource provides a comprehensive overview, highlighting the most important points and insights to help you grasp the foundational elements of the topic.
  
  Gain a comprehensive understanding of Buprenorphine, its mechanism of action, and its role in treating opioid overdoses.
  
  Understand the pharmacokinetics and pharmacodynamics of Buprenorphine.
  
  Learn about the potential side effects and contraindications of Buprenorphine.
  
  Learn about both existing and emerging Buprenorphine formulations.
  
  If you would like more detailed information, please refer to the supplementary links provided below.
- Select activity Supplementary Learning Resources:
  
  Supplementary Learning Resources:
- Select activity Buprenorphine
  
  Buprenorphine URL
  
  Read entire page (48 minutes)
  
  StatPearls Publishing LLC.-2023
- Select activity Buprenorphine Pharmacology Review: Update on Transmucosal and Long-Acting Formulations
  
  Buprenorphine Pharmacology Review: Update on Transmucosal and Long-Acting Formulations URL
  
  Read entire page (47 minutes)
  
  Journal of Addiction Medicine -2019
- Select activity Buprenorphine
  
  Buprenorphine URL
  
  Read entire page (5 minutes)
  
  SAMHSA - 2024
- Select activity Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update
  
  Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update URL
  
  Read sections 3 to 12 only (42 minutes)
  
  Expert Opinion on Pharmacotherapy - 2022
- Select activity Quiz Module 2
  
  Quiz Module 2
  
  Students must
  
  View
  
  Receive a grade
  
  Receive a passing grade
  
  To access the quiz, click on the name of the quiz provided above. On the following screen, click the attempt quiz button to view the case studies and respond to the questions.
  
  TO PASS THIS QUIZ YOU MUST OBTAIN A SCORE OF 80%.

Introduction

Course Registration

Peer Corner

Module 1: Understanding Opioids,Opioid Use Disorder and Opioid Overdose.

Drugs, Brains, and Behavior: The Science of Addiction

Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management

Opioid Use Disorder

Opioid Overdose

A conceptual model for understanding post-release opioid-related overdose risk

Therapeutic Approaches to Opioid Use Disorder: What is the Current Standard of Care?

Opioid use disorder and treatment: challenges and opportunities

How effective are medications to treat opioid use disorder?

Opioid Overdose

Opioid Overdose

Polydrug Definition and Assessment: The State of the Art

The Challenge of Polysubstance Use Overdose

Opioid overdose

Quiz Module 1

Module 2 : Overview of Buprenorphine

Buprenorphine

Buprenorphine Pharmacology Review: Update on Transmucosal and Long-Acting Formulations

Buprenorphine

Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update

Quiz Module 2

Module 3 : Buprenorphine Administration and Patient Monitoring

Emergency department‐initiated buprenorphine protocols: A national evaluation

Overview of best practices for buprenorphine initiation in the emergency department

A Guide to Expanding the Use of Buprenorphine Beyond Standard Initiations for Opioid Use Disorder

Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder

High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder

Telemedicine Flexibilities for Prescribing Controlled Medications

Emergency department‐initiated buprenorphine protocols: A national evaluation

Buprenorphine

Buprenorphine

A Patient’s Guide to Starting Buprenorphine at Home

Buprenorphine Quick Start Guide - SAMHSA

Patient Decision Aid for Medication Treatment for Opioid Use Disorder (PtDA-MOUD): Rationale, Methodology, and Preliminary Results

“Just give them a choice”: Patients' perspectives on starting medications for opioid use disorder in the ED

Quiz Module 3

Module 4 : Treatment and Referral

Overcoming Stigma and Discrimination Fundamental to OUD Care in the ED

Variation in intervention stigma among medications for opioid use disorde

Emergency Department Interventions for Opioid Use Disorde

Select Federal Policies Governing Methadone and Buprenorphine for Opioid Use Disorder

CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022

SAMHSA Overdose Prevention and Response Toolkit

Quiz Module 4

Additional Tools and Resources

COWS Score for Opiate Withdrawal

Questions for Identification of Opioid Use Disorder based on DSM-5

ED-Initiated Buprenorphine

Opioid Overdose: ED-Initiated Buprenorphine

Opioid Overdose: Harm Reduction

Adolescent Presenting with Opioid Overdose: Assessment, Intervention and Referral

Prescription Opioid Withdrawal Symptoms: Assessment, Treatment and Referral

Case Study Practice

PBL Case Study Analysis - Activity 1

PBL Case Study Analysis - Activity 2

PBL Case Study Analysis - Activity 3

PBL Case Study Analysis - Activity 4

Treatment Plan Development PBL - Activity 1

Treatment Plan Development PBL - Activity 2

Treatment Plan Development PBL - Activity 3

Treatment Plan Development PBL - Activity 4

Final Exam

Course and Self Evaluation & Certificate

Section: Module 2 : Overview of Buprenorphine | Buprenorphine Training: Treating Opioid Use Disorder | NextGenU.org

Competency covered in this module:

Module Summary:

Supplementary Learning Resources: